Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to NDORMS researcher Dr Hussein Al-Mossawi on winning one of the six European League Against Rheumatism (EULAR) Abstract Awards 2018 in Basic Science at this year's EULAR Congress.

The award refers to Hussein's work in the genetics of Ankylosing spondylitis (AS), a painful and progressive form of inflammatory arthritis, affecting around 200,000 people in the UK. AS is an autoimmune disease with a strong genetic basis and commonly occurs in men in their late teens or 20s. The disease causes inflammation in the spine and other joints, leading to pain, stiffness, and disability.

"I am delighted to receive the EULAR Abstract award in Basic Science for our work in Ankylosing spondylitis. This is recognition of how we are using resources like the UK Biobank to understand the role of genetics on immune function in this condition and we very much hope this work will help develop new treatments for patients", said Dr Al-Mossawi.

In an innovative approach, this study uses unbiased data from previously published expression quantitative trait loci (eQTL) studies to inform the relevant cell types and contexts of genetic variants involved in altering immune function AS.

The study highlights a previously unknown genetic role for Interleukin 7 (IL-7) signalling in monocytes and has implications for understanding pathogenesis across a range of diseases including multiple sclerosis.

The aim of the study was to characterise the genotypic effects of IL-7 receptor (IL7R) polymorphism on monocyte protein surface expression and soluble IL7R release. The results showed disease associated genetic variation in the IL7R gene impacts IL-7 biology in a monocyte delimited manner in the setting of inflammation.

Hear from Hussein on the research

More information

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.